Bottom line
FACDX vs GGHCX: the short answer
FACDX (Fidelity Advisor Health Care Fund) and GGHCX (INVESCO Health Care Fund) share a meaningful slice of their top holdings — about 47% by weight.
FACDX is cheaper at 0.96% vs 1.07% — a difference of $11 a year per $10,000 invested.
Over five years, GGHCX returned +2.6% a year vs +2.3% for FACDX (reporting dates differ).
GGHCX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
FACDX vs GGHCX side by side
| FACDX | GGHCX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.96% | 1.07% |
| Annual cost per $10k | $96 | $107 |
| 10-yr cost on $10k (prospectus) | $1,685 | $1,784 |
| Max front load | — | 5.5% |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +7.7% | +9.2% |
| 5-yr return (annualized) | +2.3% | +2.6% |
| 10-yr return (annualized) | +7.6% | +5.8% |
| Best quarter | +21.3% | +19.6% |
| Worst quarter | −15.0% | −16.5% |
| Net assets (fund) | $3.1B | $1.2B |
| Number of holdings | 154 | 82 |
| Portfolio turnover | 74% | 59% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FACDX | GGHCX | Difference |
|---|---|---|---|
| 2025 | +14.2% | +15.5% | −1.3% |
| 2024 | +3.9% | +4.0% | −0.1% |
| 2023 | +3.8% | +3.1% | +0.8% |
| 2022 | −13.1% | −13.5% | +0.5% |
| 2021 | +11.2% | +12.2% | −1.0% |
| 2020 | +21.1% | +14.5% | +6.6% |
| 2019 | +27.9% | +32.0% | −4.1% |
| 2018 | +7.3% | +0.5% | +6.9% |
| 2017 | +24.1% | +15.5% | +8.6% |
| 2016 | −10.3% | −11.7% | +1.4% |
Source: Fund prospectus bar charts
Holdings overlap
11 of FACDX's top 25 holdings also appear in GGHCX's top 25.
| Holding | FACDX | GGHCX |
|---|---|---|
| ELI LILLY and CO | 7.66% | 10.59% |
| Thermo Fisher Scientific Inc | 6.31% | 1.55% |
| Unitedhealth Group Inc | 4.17% | 6.17% |
| JOHNSON and JOHNSON | 3.78% | 6.76% |
| Abbvie Inc | 3.62% | 4.03% |
| Argenx Se | 2.09% | 3.24% |
| MERCK and CO INC | 2.09% | 4.59% |
| Guardant Health Inc | 1.48% | 2.04% |
| Waters Corp | 1.43% | 1.41% |
| Cvs Health Corp | 1.29% | 2.52% |
| Gilead Sciences Inc | 1.25% | 3.63% |
Source: SEC Form N-PORT
FACDX top 10
- ELI LILLY and CO — 7.66%
- Danaher Corp — 6.75%
- Thermo Fisher Scientific Inc — 6.31%
- Unitedhealth Group Inc — 4.17%
- JOHNSON and JOHNSON — 3.78%
- Abbvie Inc — 3.62%
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- MERCK and CO INC — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
FAQ
What is the difference between FACDX and GGHCX?
Which is cheaper, FACDX or GGHCX?
Should I own both FACDX and GGHCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.